A Rare Genetic Disorder Linked to Type 1 Diabetes and Multiple Autoimmune Conditions
Researchers documented a case of an ultra-rare genetic disorder that disrupts immune system regulation and led to Type 1 diabetes alongside thyroid disease and growth problems. The finding expands what doctors know about how genetic variations can affect multiple body systems.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- ADMFD (autoimmune disease, multisystem, with facial dysmorphism) is an extremely rare inherited disorder caused by mutations in the ITCH gene, which helps control immune system balance
- This case is the first documented in someone of Egyptian origin, suggesting the condition may occur in populations beyond North America and Western Europe
- The patient developed Type 1 diabetes at age 16 alongside Hashimoto thyroiditis and other endocrine problems, highlighting how genetic immune disorders can affect multiple hormone-producing glands
- Fewer than 15 cases of ADMFD have been reported worldwide, making it difficult for doctors to recognize and understand the full range of symptoms
- The case reveals new features of ADMFD—including pituitary and pineal gland involvement—that had not been documented before
Understanding ADMFD: A Genetic Immune Disorder
ADMFD (autoimmune disease, multisystem, with facial dysmorphism) is an ultra-rare genetic condition that affects how the immune system works. It develops when a person inherits two non-working copies of the ITCH gene—one from each parent. The ITCH gene produces a protein that acts like a traffic controller for the immune system, helping to keep it balanced and prevent it from attacking the body's own cells.
Because ADMFD is so rare, with fewer than 15 cases reported in medical literature, doctors and researchers are still learning about all the ways it can affect people. Until now, most documented cases have been in patients from North America and Western Europe.
A New Case Expands What We Know
Doctors recently described the case of a teenage girl of Egyptian origin living in the United Arab Emirates who was diagnosed with ADMFD. She carried a previously unknown ITCH mutation—meaning this variant had not been identified before. Her diagnosis came at age 15 through genetic testing that looked at 145 genes linked to various conditions.
Before her ADMFD diagnosis, she had been evaluated for other health problems starting at age 8, including severe short stature, delayed puberty, and an underactive thyroid. Genetic testing at the time had ruled out growth hormone deficiency, but doctors did not yet have a complete explanation for her symptoms.
Type 1 Diabetes and Other Autoimmune Complications
At age 16, the patient developed Type 1 diabetes and presented with diabetic ketoacidosis, a serious condition requiring urgent medical care. Blood tests confirmed autoimmune Type 1 diabetes, showing positive antibodies against glutamic acid decarboxylase and insulin—markers that the immune system was attacking insulin-producing cells.
The case revealed that this patient also had Hashimoto thyroiditis, an autoimmune condition affecting the thyroid gland. This finding illustrates an important pattern: when one autoimmune condition is present, particularly in the context of a genetic immune disorder, others often develop as well. With proper treatment, the patient's blood sugar control improved significantly.
New Clinical Features and Remaining Questions
This case added new findings to the medical understanding of ADMFD. Brain imaging revealed enlargement of the pituitary gland—the master gland that controls many hormones—and a growing cyst in the pineal gland, a small structure deep in the brain. These pituitary and pineal abnormalities had never been documented in ADMFD patients before.
Unlike previously reported cases, this patient did not have liver or gastrointestinal involvement. This suggests that ADMFD may present differently in different people, with some individuals showing mainly endocrine (hormone-related) symptoms rather than problems affecting the digestive system. Doctors recommend that patients with ADMFD continue to be monitored for liver and gastrointestinal issues, as these remain possible complications of the condition.
What This Means for Diagnosis and Care
Because ADMFD is so rare and can look different from person to person, it is easy for doctors to miss. This case demonstrates the importance of genetic testing when patients have multiple autoimmune conditions together, especially alongside unusual growth or developmental patterns.
The discovery of a new ITCH variant in a patient of Egyptian descent also suggests that ADMFD may be found in people around the world who have not yet been diagnosed. As genetic testing becomes more available and doctors become more aware of this condition, additional cases may be identified, helping researchers better understand how the ITCH gene protects immune health.
Evidence label
Source: JCEM case reports. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
From Type1Cure
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Research summaryDiagnosis & Early DetectionA Simple Blood Test May Help Doctors Assess How Severe Your DKA IsPubMed indexed literature
- Research summaryDiagnosis & Early DetectionA New Approach to Finding Type 1 Diabetes Early: Testing During Routine CheckupsPubMed indexed literature
- Research summaryDiagnosis & Early DetectionSingle Autoantibody: What It Means When Your Child Tests Positive for One Type 1 MarkerPubMed indexed literature
- Research summaryDiagnosis & Early DetectionKetosis-Prone Type 2 Diabetes: New Clues to an Immune Mix-UpPubMed indexed literature
- Research summaryDiagnosis & Early DetectionWhy Screening for Type 1 Diabetes Before Symptoms MatterPubMed indexed literature
- Research summaryDiagnosis & Early DetectionTesting for Type 1 Before Symptoms Appear: What a Real-World Pilot LearnedPubMed indexed literature